Ex3 Psychoactive Rx Flashcards

1
Q

onset for antidepressants

A

Up to 2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Generally - ok to hold medications?

A

No, unless NPO/high TF residuals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

TCA medications

A

end in “triptyline”, “ipramine”, “epin”

amitriptyline, imipramine, desipramine, doxepin, nortriptyline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

TCA indications

A

depression

unique: chronic pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

TCA MOA

A
  1. inhibit Serotonin/Norepi reuptake

2. Antagonistic: histamine, anti-muscarinic acetylcholine, alpha1 adrenergic, NMDA, mu opioid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Metabolism of TCAs

A

Liver - P450

Active metabolites, erratic bioavailability, long half life (>24h)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

TCA common side effects

A
  1. Hypotension (increased in elderly)
  2. Anticholinergic/antihistmaine: Urinary retention
  3. fine tremors, Sedation, confusion, delirium
  4. Prolonged QTc (Check EKG prior to case)
  5. Gastric motility, ileus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

TCA dosage effect

A

narrow therapeutic index: EKG changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Risk of TCA

A

Reduced seizure threshold
Serotonin Syndrome (avoid w/ MAOI)
Withdrawal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

TCA anesthesia considerations

A

Exaggerated (new) or Diminished (chronic) response to sympathomimetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Benadryl/Scopolamine w/ TCA

A

additive effects - excess sedation/confusion/delirium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

SSRI metabolism

A

Liver via CYP450

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Longest acting SSRI

A

Fluoxetine, 1-4 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Shortest acting SSRI

A

Fluvoxamine, 15h

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which SSRI would it be okay to miss a few doses (days) without issues?

A

Fluoxetine (d/t long half life + active metabolite)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Side effects of SSRIs

A

BBW: suicide under age 24

Hyponatremia (SIADH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

adverse effects of escitalopram/citalopram

A

QTc prolongation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

SSRI withdrawal

A

1-7 days after d/c

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Which SSRI should you be concerned with withdrawal in OR?

A

Fluvoxamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

SSRI risk

A

serotonin syndrome - MAOIs, opioids, linezolid, methylene blue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

AE mirtazipine

A

decreased seizure threshold

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

SNRIs

A

venlafaxine, duloxetine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

SNRI indications

A

depression, pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

AE SNRIs

A

withdrawal (1/2 life=5 hours), active metabolites

Decreased seizure threshold

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
clinical indications - trazodone/nefazodone
depression, insomnia
26
AEs trazodone/nefazodone
sedation, orthostatic hypotension, QT prolongation, impairment of platelet aggregation
27
S/S serotonin syndrom
hyperthermia, confusion, agitation, autonomic hyperactivity, myoclonus, hyperreflexia, diaphoresis, tremor, diarrhea, neuromuscular abnormalities, ocular clonus
28
risk of serotonin syndrome occurs with
serotonin inhibitors + antiemetic (zofran/reglan), fentanyl, linezolid, meperidine, tramadol, valproic acid
29
Tx serotonin syndrome
1. stop offending agent | 2. serotonin antagonists (cyproheptadine)
30
prevention of serotonin syndrome
14 day washout
31
inadequate analgesia may occur in serotonin inhibitors with
codeine
32
increased risk of _____ in serotonin inhibitors
bleeding
33
used for smoking cessation
bupropion
34
MOA norepi/dopa reuptake
bupropion
35
AE Bupriopion
abrupt w/d=seiz risk | increased HR/BP
36
MAOIs
phenelzine, selegiline, tranylcypromine
37
MOA MAOIs
inhibits MAO (monoamine oxidase enzyme) which breaks down Serotonin/norepi/dopa
38
MAOI Rx Intxns
Opiates, meperidine, any Rx that effects serotonin = serotonin syndrome
39
AE MAOIs
myoclonic movements
40
Decreased use of MAOIs
intxn w/ tyramine (cheese/wine)
41
Effect of tyramine + MAOIs
HTN, tachycardia
42
Contraindicated with MAOIs
meperidine
43
DOC - patient with serotonin syndrome has pain
morphine
44
Cautious during use of _____ with MAOIs
vasopressors - exaggerated response
45
Etomidate is ____ to use with MAOIs
safe
46
Goal serum concentration - Lithium
0.6-1 mEq/L
47
Chronic Side Effects - Lithium
nephrogenic diabetes insipidus, polyuria/polydipsia, hypothyroidism, myxedema coma
48
Lithium overdose
CNS effects - seizures, coma, tremor, ventricular arrhythmias, t wave inversion, confusion, N/V/D
49
Increases risk of Lithium Toxicity
Renal insufficiency, hyponatremia
50
Drug interactions to monitor for w/ Lithium
Thiazide Diuretics, Loop diuretics, NSAIDs, neuroleptic Rx, neuromuscular blockade
51
AE Lithium + neuromuscular blockade
prolonged duration of NMBA
52
AE Lithium + diuretic/NSAIDs
Altered Sodium excretion --> renal effect --> increased lithium plasma concentration
53
AE Lithium + neuroleptic drugs
i.e. reglan | increased EPS, increased risk neuroleptic malignant syndrome
54
Typical antipsychotics
chlorpromazine, droperidol, fluphenazine, haloperidol, prochlorperazine
55
Atypical antipsychotics
aripiprazole, olanzipine, quetapine, risperidone, ziprasidone, loxapine, clozapine
56
MOA antipsychotics
"dirty" - typical vs. atypical
57
MOA typical antipsychotics
High D2 antagonism, Low 5HT-2A antagonism
58
MOA atypical antipsychotics
Moderate-high D2 antagonism, High 5-HT2A antagonism
59
Clozapine AEs
agranulocytosis (1st 3months), myocarditis/cardiomyopathy, seizures
60
antipsychotic side effects
QTc prolongation**, postural hypotension, sedation, EPS, akathisia, tardive dyskinesia, urinary retention, blurred vision, dystonia
61
Tardive dyskinesia presentation
repetitive/jerking movements in face, neck, tongue, lips (may affect breathing/swallowing)
62
Dystonia presentation
sustained muscle contractions (twisting, repetitive movements, abnormal postures), tremor/loss of facial expressions, skeletal muscle rigidity
63
Tardive dyskinesia tx
no treatment - anticholinergics worsen symptoms
64
Dystonia tx
IV benadryl 25-50 mg benztropine 2mg dose reduction/avoidance
65
akathesia
restlessness, urge to move
66
akathesia tx
propranolol (1st line), benzos, anticholinergic (benztropine), amantadine, clonidine
67
Parkinsonism
muscle rigidity, tremor, bradykinesia, postural abnormalities, salivation
68
parkinsonism tx
dose reduction/drug avoidance + anticholinergic (benztropine)
69
risk of antipsychotics
neuroleptic malignant syndrome
70
how to differentiate between NMS/serotonin syndrome
history
71
s/s neuroleptic malignant syndrome
Fever** | renal failure, rhabdo, rigidity, altered LOC, autonomic dysfunction
72
Tx NMS
dantrolene 0.5-2.5mg/kg q6h
73
NMS may mimic
malignant hyperthermia
74
benzos act on
Alpha/Gamma subunit of GABA-A receptor
75
benzodiazepine metabolism
significant hepatic metabolism | some rx = active metabolites
76
Benzodiazepines with active metabolites
midazolam, diazepam, chlordiazepoxide (Librium)
77
Benzodiazepines with inactive metabolites
oxazepam, lorazepam, temazepam
78
DOC benzo (renal insufficiency, repeated doses)
Lorazepam
79
Anesthesiology considerations in patients taking Benzos
- additive effects w/ other sedatives | - abrupt stopping of chronic therapy = w/d